• Search Research Projects
  • Search Researchers
  • How to Use
  1. Back to previous page

Research for specific gene expression and its clinical use of pancreatic ductal adenocarcinoma utilizing a gene expression database by NGS-HiCEP method

Research Project

Project/Area Number 20K17667
Research Category

Grant-in-Aid for Early-Career Scientists

Allocation TypeMulti-year Fund
Review Section Basic Section 55020:Digestive surgery-related
Research InstitutionKurume University

Principal Investigator

Takao Mikiya  久留米大学, 医学部, 助教 (70821924)

Project Period (FY) 2020-04-01 – 2024-03-31
Project Status Completed (Fiscal Year 2023)
Budget Amount *help
¥4,160,000 (Direct Cost: ¥3,200,000、Indirect Cost: ¥960,000)
Fiscal Year 2023: ¥390,000 (Direct Cost: ¥300,000、Indirect Cost: ¥90,000)
Fiscal Year 2022: ¥780,000 (Direct Cost: ¥600,000、Indirect Cost: ¥180,000)
Fiscal Year 2021: ¥1,300,000 (Direct Cost: ¥1,000,000、Indirect Cost: ¥300,000)
Fiscal Year 2020: ¥1,690,000 (Direct Cost: ¥1,300,000、Indirect Cost: ¥390,000)
Keywords浸潤性膵管癌 / 早期診断 / 予後マーカー / 包括的高感度転写産物プロファイリング:HiCEP / 次世代シークエンシング:NGS / 膵癌 / 次世代シークエンサー:NGS / HiCEP法 / 次世代シークエンサー / 腫瘍マーカー
Outline of Research at the Start

浸潤性膵管癌(以下膵癌)は他の癌と比較して悪性度が高く、極端に予後不良な「21世紀に残された消化器癌」と言われ、その対策は急務である。膵癌細胞の分子的背景は不明な点が多く、その特性を解析して非侵襲的早期診断や治療効果の向上に繋げる技術開発が求められている。

Outline of Final Research Achievements

Although pancreatic ductal adenocarcinoma (PDAC) is one of the most lethal cancers due to a dismal survival rate, its biomarkers currently used in clinical practice are neither sufficiently sensitive nor specific. Previously, high coverage gene expression profiling (HiCEP) method was reported as an AFLP-based comprehensive gene expression analysis developed in Japan.
We aimed to identify transcriptional products specific to PDAC by developing a database using HiCEP method and next-generation sequencing (NGS) method in surgical tissues and peripheral blood samples from approximately 90 cases. We identified several novel genes whose expression levels were significantly increased in cancer tissues compared to non-cancerous tissues. We have replicated these results by real-time PCR in other case specimens, and also compared them with clinical database. In addition, we have performed a spatial transcriptome analysis and are now investigating the results.

Academic Significance and Societal Importance of the Research Achievements

実臨床において膵癌の早期発見や予後予測に関する有効な診断マーカーは確立していない。本研究において、未知遺伝子を含むmRNAに対して高感度かつ網羅的、定量的な発現解析を行うことが可能であり、再現性を確認することができた。NGS-HiCEP法により網羅的な発現データベースを作成することが可能となり、他癌腫への応用や、さらなる研究発展により未だ確立されていない早期診断技術、予後マーカー等の臨床応用に期待できる。

Report

(5 results)
  • 2023 Annual Research Report   Final Research Report ( PDF )
  • 2022 Research-status Report
  • 2021 Research-status Report
  • 2020 Research-status Report
  • Research Products

    (9 results)

All 2022 2021 2020

All Presentation (9 results) (of which Int'l Joint Research: 2 results)

  • [Presentation] A resected case of synchronous autoimmune pancreatitis and high-grade pancreatic intraepithelial neoplasia(PanIN-3)2022

    • Author(s)
      高尾幹也、脊山泰治、横山真太郎、谷圭吾、冲永裕子、 仲程純、堀口慎一郎
    • Organizer
      第26回国際膵臓学会/第53回日本膵臓学会
    • Related Report
      2022 Research-status Report
    • Int'l Joint Research
  • [Presentation] NGS-HiCEP法による淡明型腎細胞癌・膵管腺癌の腫瘍マーカー候補の同定2022

    • Author(s)
      北村陽典、中山昌喜、辻田裕二郎、川口真、高尾幹也、清水聖子、岩屋啓一、河村優輔、豊田優、津田均、四ノ宮成祥、岸庸二、伊藤敬 一、松尾洋孝
    • Organizer
      第6回Liquid Biopsy研究会
    • Related Report
      2021 Research-status Report
  • [Presentation] NGS-HiCEP法による腎細胞癌の腫瘍マーカー候補の同定2022

    • Author(s)
      北村陽典、中山昌喜、辻田裕二郎、川口真、高尾幹也、清水聖子、中岡博史、岩屋啓一、斎藤俊行、豊田優、河村優輔、高田雄三、湯野川 春信、荒木良子、安倍真澄、津田均、四ノ宮成祥、松尾洋孝、伊藤敬一
    • Organizer
      第31回泌尿器科分子・細胞研究会
    • Related Report
      2021 Research-status Report
  • [Presentation] NGS-HiCEP identifies candidate tumor markers in clear cell renal cell carcinoma and pancreatic ductal adenocarcinoma.2021

    • Author(s)
      Yosuke Kitamura, Akiyoshi Nakayama, Yujiro Tsujita, Makoto Kawaguchi, Mikiya Takao, Seiko Shimizu, Keiichi Iwaya, Yusuke Kawamura, Yu Toyoda, Hitoshi Tsuda, Nariyoshi Shinomiya, Yoji Kishi, Keiichi Ito, Hirotaka Matsuo
    • Organizer
      The 80th Annual Meeting of the Japanese Cancer Association
    • Related Report
      2021 Research-status Report
  • [Presentation] HiCEP法と次世代シークエンシングを併用した膵癌マーカーの同定2021

    • Author(s)
      前原一輝, 高尾幹也, 松尾洋孝, 荒木良子, 清水聖子, 中山昌喜, 瀧端康博, 永生高広, 北村陽典, 川口真, 河村優輔, 森友理乃, 田中里沙, 安倍真澄, 伊藤敬一, 四ノ宮成祥, 岸庸二
    • Organizer
      第66回防衛衛生学会, 2020
    • Related Report
      2020 Research-status Report
  • [Presentation] Development of a gene expression database of pancreatic ductal adenocarcinoma cases by NGS-combined HiCEP to identify tumor markers2020

    • Author(s)
      Takao M, Matsuo H, Araki R, Shimizu S, Kawaguchi M, Nakayama A, Kitamura Y, Kawamura Y, Maehara K, Abe M, Ito K, Hoshikawa M, Yamamoto J, Kishi Y, Shinomiya N
    • Organizer
      American Association for Cancer Research (AACR) 2020.
    • Related Report
      2020 Research-status Report
    • Int'l Joint Research
  • [Presentation] Identification of candidate tumor marker genes for pancreatic ductal adenocarcinoma tissue by NGS-HiCEP method2020

    • Author(s)
      Takao M, Matsuo H, Shimizu S, Kitamura Y, Kawaguchi M, Nakayama A, Kawamura Y, Ito K, Kishi Y, Shinomiya N
    • Organizer
      第79回日本癌学会学術総会, 2020
    • Related Report
      2020 Research-status Report
  • [Presentation] The use of NGS-HiCEP to build an extensive renal cell carcinoma gene expression database for identifying tumor markers2020

    • Author(s)
      Shimizu S, Matsuo H, Kawaguchi M, Nakayama A, Takao M, Kitamura Y, Tsujita Y, Kawamura Y, Ito K, Shinomiya N
    • Organizer
      第79回日本癌学会学術総会, 2020
    • Related Report
      2020 Research-status Report
  • [Presentation] 次世代シークエンシングの併用によるHiCEP法(NGS-HiCEP法)の開発―腎癌組織の網羅的遺伝子発現データベースの構築と腎癌マーカーの同定2020

    • Author(s)
      前原一輝, 川口真, 松尾洋孝, 荒木良子, 清水聖子, 高尾幹也, 中山昌喜, 北村陽典, 辻田裕二郎, 河村優輔, 堀江美音, 藤原慎, 湯野川春信, 安倍真澄, 伊藤敬一, 四ノ宮成祥
    • Organizer
      第38回日本ヒト細胞学会学術集会(高知), 2020
    • Related Report
      2020 Research-status Report

URL: 

Published: 2020-04-28   Modified: 2025-01-30  

Information User Guide FAQ News Terms of Use Attribution of KAKENHI

Powered by NII kakenhi